Breast cancer is the most common cancer in women worldwide. The majority of breast
cancers show overexpression of estrogen receptors (ERs) and progesterone receptors …

The higher incidence of breast cancer in developed countries has been tempered by
reductions in mortality, largely attributable to mammographic screening programmes and …

Background Previous studies have suggested that breast cancer risk factors are associated
with estrogen receptor (ER) and progesterone receptor (PR) expression status of the tumors …

Introduction. ER, PR, and HER2 are routinely available in breast cancer specimens. The
purpose of this study is to contrast breast cancer‐specific survival for the eight ER/PR/HER2 …

Objectives Physical inactivity and sedentary behaviour are associated with higher breast
cancer risk in observational studies, but ascribing causality is difficult. Mendelian …

Breast cancer research examining either molecular profiles or biomarker subtypes has
focused on the estrogen receptor negative/progesterone receptor negative/human …

Importance Steroid hormone receptors, including estrogen receptor (ER) and progesterone
receptor (PR), are crucial biomarkers in breast cancer (BC). However, limited data are …

Current clinical management of breast cancer relies on the availability of robust
clinicopathological variables and few well-defined biological markers. Recent microarray …

Background Response to endocrine therapy in breast cancer correlates with estrogen
receptor (ER) and progesterone receptor (PR) status. Generally, hormone receptor-positive …

Most breast cancers are driven by oestrogen receptor-α. Anti-oestrogenic drugs are the
standard treatment for these breast cancers; however, treatment resistance is common …